| Christopher J Van Hofwegen, MD | |
|
2979 Squalicum Pkwy Ste 203, Bellingham, WA 98225-1813 | |
| (360) 733-7670 | |
| Not Available |
| Full Name | Christopher J Van Hofwegen |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 20 Years |
| Location | 2979 Squalicum Pkwy Ste 203, Bellingham, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376751669 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0005X | Orthopaedic Surgery - Sports Medicine | MD 60130985 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Hospital | Bellingham, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Proliance Surgeons Inc Ps | 8527972900 | 388 |
News Archive
In the bustling economy of the cell, little bubbles called vesicles serve as container ships, ferrying cargo to and from the port - the cell membrane. Some of these vesicles, called post-Golgi vesicles, export cargo made by the cell's protein factory.
It is a widely known that, as women age, it becomes more difficult for them to become pregnant. In a study from the Weill Medical College of Cornell University, researchers documented that it is also increasingly more likely that older IVF mothers will suffer a pregnancy loss, most often due to cytogenetic abnormalities of the fetus.
A new randomized, prospective trial has shown that orlistat, a commonly prescribed inhibitor of fat absorption, does not help patients with fatty liver disease (FLD) lose weight, nor does it improve their liver enzymes or insulin resistance.
"Republican lawmakers have long touted federal tort reform as way to bring down health-care costs. Democrats are coming around to the same position in response to what they've heard from constituents. ... President Barack Obama recently raised the issue as an olive branch to Republicans, directing the Department of Health and Human Services to spend $25 million to help states and health-care systems try alternative methods of resolving malpractice allegations."
Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company"), a medical device company focused on infectious disease and dermatology, today provided an update to a previously announced exclusive cooperative research and development (the "Agreement") with MAST BioSurgery Inc. ("MAST") for the development of one or more new surgical products incorporating Ceragenix's CeraShield™ antimicrobial technology.
› Verified 1 days ago
| Entity Name | Proliance Surgeons Inc Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023170313 PECOS PAC ID: 8527972900 Enrollment ID: O20031119000128 |
News Archive
In the bustling economy of the cell, little bubbles called vesicles serve as container ships, ferrying cargo to and from the port - the cell membrane. Some of these vesicles, called post-Golgi vesicles, export cargo made by the cell's protein factory.
It is a widely known that, as women age, it becomes more difficult for them to become pregnant. In a study from the Weill Medical College of Cornell University, researchers documented that it is also increasingly more likely that older IVF mothers will suffer a pregnancy loss, most often due to cytogenetic abnormalities of the fetus.
A new randomized, prospective trial has shown that orlistat, a commonly prescribed inhibitor of fat absorption, does not help patients with fatty liver disease (FLD) lose weight, nor does it improve their liver enzymes or insulin resistance.
"Republican lawmakers have long touted federal tort reform as way to bring down health-care costs. Democrats are coming around to the same position in response to what they've heard from constituents. ... President Barack Obama recently raised the issue as an olive branch to Republicans, directing the Department of Health and Human Services to spend $25 million to help states and health-care systems try alternative methods of resolving malpractice allegations."
Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company"), a medical device company focused on infectious disease and dermatology, today provided an update to a previously announced exclusive cooperative research and development (the "Agreement") with MAST BioSurgery Inc. ("MAST") for the development of one or more new surgical products incorporating Ceragenix's CeraShield™ antimicrobial technology.
› Verified 1 days ago
| Entity Name | Peacehealth United General Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548698806 PECOS PAC ID: 6103056288 Enrollment ID: O20140507000955 |
News Archive
In the bustling economy of the cell, little bubbles called vesicles serve as container ships, ferrying cargo to and from the port - the cell membrane. Some of these vesicles, called post-Golgi vesicles, export cargo made by the cell's protein factory.
It is a widely known that, as women age, it becomes more difficult for them to become pregnant. In a study from the Weill Medical College of Cornell University, researchers documented that it is also increasingly more likely that older IVF mothers will suffer a pregnancy loss, most often due to cytogenetic abnormalities of the fetus.
A new randomized, prospective trial has shown that orlistat, a commonly prescribed inhibitor of fat absorption, does not help patients with fatty liver disease (FLD) lose weight, nor does it improve their liver enzymes or insulin resistance.
"Republican lawmakers have long touted federal tort reform as way to bring down health-care costs. Democrats are coming around to the same position in response to what they've heard from constituents. ... President Barack Obama recently raised the issue as an olive branch to Republicans, directing the Department of Health and Human Services to spend $25 million to help states and health-care systems try alternative methods of resolving malpractice allegations."
Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company"), a medical device company focused on infectious disease and dermatology, today provided an update to a previously announced exclusive cooperative research and development (the "Agreement") with MAST BioSurgery Inc. ("MAST") for the development of one or more new surgical products incorporating Ceragenix's CeraShield™ antimicrobial technology.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher J Van Hofwegen, MD 2979 Squalicum Pkwy Ste 203, Bellingham, WA 98225-1813 Ph: (360) 733-7670 | Christopher J Van Hofwegen, MD 2979 Squalicum Pkwy Ste 203, Bellingham, WA 98225-1813 Ph: (360) 733-7670 |
News Archive
In the bustling economy of the cell, little bubbles called vesicles serve as container ships, ferrying cargo to and from the port - the cell membrane. Some of these vesicles, called post-Golgi vesicles, export cargo made by the cell's protein factory.
It is a widely known that, as women age, it becomes more difficult for them to become pregnant. In a study from the Weill Medical College of Cornell University, researchers documented that it is also increasingly more likely that older IVF mothers will suffer a pregnancy loss, most often due to cytogenetic abnormalities of the fetus.
A new randomized, prospective trial has shown that orlistat, a commonly prescribed inhibitor of fat absorption, does not help patients with fatty liver disease (FLD) lose weight, nor does it improve their liver enzymes or insulin resistance.
"Republican lawmakers have long touted federal tort reform as way to bring down health-care costs. Democrats are coming around to the same position in response to what they've heard from constituents. ... President Barack Obama recently raised the issue as an olive branch to Republicans, directing the Department of Health and Human Services to spend $25 million to help states and health-care systems try alternative methods of resolving malpractice allegations."
Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company"), a medical device company focused on infectious disease and dermatology, today provided an update to a previously announced exclusive cooperative research and development (the "Agreement") with MAST BioSurgery Inc. ("MAST") for the development of one or more new surgical products incorporating Ceragenix's CeraShield™ antimicrobial technology.
› Verified 1 days ago
Warren S Taranow, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3015 Squalicum Pkwy, Bellingham, WA 98225 Phone: 360-733-2092 Fax: 360-733-4013 | |
Thiran Udawatta, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2979 Squalicum Pkwy Ste 203, Bellingham, WA 98225 Phone: 360-733-7670 Fax: 360-647-1901 | |
Dr. Leonard B Kolodychuk, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3015 Squalicum Pkwy, Bellingham, WA 98225 Phone: 360-738-2200 Fax: 360-733-4013 | |
Jason W Dahl, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2979 Squalicum Pkwy Ste 203, Bellingham, WA 98225 Phone: 360-733-7670 Fax: 763-520-7580 | |
John Loch Trimingham, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4280 Meridian St, Suite 110, Bellingham, WA 98226 Phone: 360-788-7733 Fax: 360-676-7471 | |
Ronald Yg Woo, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 3015 Squalicum Pkwy, Bellingham, WA 98225 Phone: 360-733-2092 Fax: 360-733-4013 | |
Carla S Smith, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3015 Squalicum Pkwy Ste 200, Bellingham, WA 98225 Phone: 360-733-2092 Fax: 360-788-6042 |